Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-437.97%
operating margin TTM
-446.85%
revenue TTM
7.20 Million
revenue per share TTM
0.12$
valuation ratios | |
|---|---|
| pe ratio | -1.39 |
| peg ratio | -0.08 |
| price to book ratio | 3.23 |
| price to sales ratio | 6.18 |
| enterprise value multiple | -1.90 |
| price fair value | 3.23 |
profitability ratios | |
|---|---|
| gross profit margin | -11.76% |
| operating profit margin | -446.85% |
| pretax profit margin | -437.97% |
| net profit margin | -437.97% |
| return on assets | -126.35% |
| return on equity | -172.12% |
| return on capital employed | -224.29% |
liquidity ratio | |
|---|---|
| current ratio | 1.84 |
| quick ratio | 1.84 |
| cash ratio | 1.64 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 37.14 |
| days of payables outstanding | 99.28 |
| cash conversion cycle | -62.14 |
| receivables turnover | 9.83 |
| payables turnover | 3.68 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.28 |
| debt equity ratio | 0.51 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.34 |
| interest coverage | -52.07 |
| cash flow to debt ratio | -4.09 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.49 |
| cash per share | 0.30 |
| operating cash flow per share | -0.49 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -4.09 |
| short term coverage ratios | -8.38 |
| capital expenditure coverage ratio | -550.44 |
Frequently Asked Questions
When was the last time Cue Biopharma, Inc. (NASDAQ:CUE) reported earnings?
Cue Biopharma, Inc. (CUE) published its most recent earnings results on 14-11-2024.
What is Cue Biopharma, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Cue Biopharma, Inc. (NASDAQ:CUE)'s trailing twelve months ROE is -172.12%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Cue Biopharma, Inc. (CUE) currently has a ROA of -126.35%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CUE's net profit margin stand at?
CUE reported a profit margin of -437.97% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CUE's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.84 in the most recent quarter. The quick ratio stood at 1.84, with a Debt/Eq ratio of 0.51.